Schedule 13G ownership disclosure

AUTOLUS THERAPEUTICS LTD

Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share · CUSIP: 05280R100

Event date: 2025-06-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MAK Capital Fund LP

    Shares: 15,408,638.00 · Class: 5.8%

  • MAK Capital One L.L.C.

    Shares: 15,408,638.00 · Class: 5.8%

  • Michael A. Kaufman

    Shares: 15,408,638.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-25-000184
Form type
SCHEDULE 13G
Filer
Autolus Therapeutics plc
CIK
CIK 1730463
Filed
Jun 25, 2025
Reporting period
Jun 17, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub